Abstract
The report covers a forecast and an analysis of the chronic disease management market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2024 based on revenue (USD Billion). The study includes drivers and restraints of the chronic disease management market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the chronic disease management market on a global and regional level.
In order to give the users of this report a comprehensive view of the chronic disease management market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the chronic disease management market by segmenting the market based on disease type, delivery mode, service, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2024.
By disease type, the chronic disease management market is divided into arthritis, cardiovascular disease, cancer, and diabetes. By delivery mode, the chronic disease management market is bifurcated into cloud-based and on-premises. By service, the market is segmented into educational services, implementation service, consulting service, and others. The end-user segment of the chronic disease management market includes providers, payers, and others. Providers are further segmented into ambulatory care centers, hospitals, physician groups, and integrated delivery networks, diagnostic and imaging centers, home healthcare agencies, nursing homes, and assisted living facilities, and others. The payers segment is further divided into public payers and private payers.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, the UK, China, Japan, India, and Brazil.
Some key players of the global chronic disease management market are TriZetto Corporation, Infosys Limited, Pegasystems Inc., Siemens Healthcare Private Limited, MINES & Associates, Inc., Allscripts Healthcare Solutions, Inc., HealthSmart Holdings, Inc., Wellcentive, Inc., EXL Healthcare, Phytel Inc., Harmony Information Systems, Inc., and ScienceSoft USA Corporation.
This report segments the global chronic disease management market into:
Global Chronic Disease Management Market: By Disease Type
Arthritis
Cardiovascular Disease
Cancer
Diabetes
Others
Global Chronic Disease Management Market: By Delivery Mode
Cloud-Based
On-Premises
Global Chronic Disease Management Market: By Service
Educational Implementation Service
Implementation Service
Consulting Service
Others
Global Chronic Disease Management Market: By End-User
Providers
Ambulatory Care Centers
Hospitals, Physician Groups, and Integrated Delivery Networks
Diagnostic and Imaging Centers
Home Healthcare Agencies, Nursing Homes, and Assisted Living Facilities
Others
Payers
Public Payers
Private Payers
Others
Global Chronic Disease Management Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa